| Health / Medical Topics |
Sobuzoxane
The orally available active prodrug of ICRF-154, a bisdioxopiperazine derivative, with cardioprotective and antineoplastic activities. Like other ICRF compounds, sobuzoxane and its active metabolite ICRF-154 interfere with topoisomerase II activity prior to the formation of intermediate cleavable DNA-enzyme complexes during the catalytic cycle resulting in tumor cell growth inhibition. Furthermore, sobuzoxane chelates metal cations thereby limiting the formation of free radical-generating anthracycline-metal complexes and may prevent anthracycline-induced oxidative damage to cardiac and soft tissues. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called TZT-1027.
A thyroid hormone receptor isoform beta-1 liver-selective analog with antilipidemic and antiatherosclerotic activity. In animal models sobetirome reduced serum lipids, decreased cholesterol…
A question associated with the SOAPP-R questionnaire.
Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R) How often have you worried about being left alone?
Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R) How often have you been treated for an alcohol or drug…
Screener and Opioid Assessment for Patients with Pain - Revised (SOAPP-R) Score.
